Details for Patent: 11,564,916

Which drugs does patent 11,564,916 protect, and when does it expire?

Patent 11,564,916 protects KALYDECO, ORKAMBI, TRIKAFTA (COPACKAGED), and SYMDEKO (COPACKAGED), and is included in seven NDAs.

This patent has eighty patent family members in thirty countries.

Drugs Protected by US Patent 11,564,916

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Vertex Pharms Inc	KALYDECO	ivacaftor	GRANULE;ORAL	207925-004	May 3, 2023		RX	Yes	No						TREATMENT OF CF IN A PATIENT AGE 1 MONTH TO
Vertex Pharms Inc	KALYDECO	ivacaftor	GRANULE;ORAL	207925-005	May 3, 2023		RX	Yes	No						TREATMENT OF CF IN A PATIENT AGE 1 MONTH TO
Vertex Pharms Inc	KALYDECO	ivacaftor	GRANULE;ORAL	207925-003	Apr 29, 2019		RX	Yes	No						TREATMENT OF CF IN A PATIENT AGE 4 MONTHS TO
Vertex Pharms Inc	KALYDECO	ivacaftor	GRANULE;ORAL	207925-001	Mar 17, 2015		RX	Yes	No						TREATMENT OF CF IN A PATIENT AGE 4 MONTHS TO
Vertex Pharms Inc	KALYDECO	ivacaftor	GRANULE;ORAL	207925-002	Mar 17, 2015		RX	Yes	Yes						TREATMENT OF CF IN A PATIENT AGE 4 MONTHS TO
Vertex Pharms Inc	ORKAMBI	ivacaftor; lumacaftor	GRANULE;ORAL	211358-003	Sep 2, 2022		RX	Yes	No						TREATMENT OF CF IN A PATIENT AGE 1 TO

International Family Members for US Patent 11,564,916

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009282419
Australia	2010282986
Australia	2016216569
Australia	4147401
Brazil	112012008082
Brazil	PI0916877